Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. SC 13G Stake Amended Statement of Ownership
  2. 424B3 Offering Prospectus
  3. 424B3 Offering Prospectus
  4. EFFECT Other Notice of Effectiveness
  5. EFFECT Other Notice of Effectiveness
  6. SC 13G/A Stake Amended Statement of Ownership
  7. POS AM Other Post-effective Amendment for Registration Statement
  8. POS AM Other Post-effective Amendment for Registration Statement
  9. 10-K Report Annual Report
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Other events
  13. 4 Insider Changes in Ownership
  14. 3/A Insider 3/A
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 38 of 42 · 833 filings